Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: enough

Discussions of the share price/volume are very much on topic when it comes to any publicly traded stock.  

I can agree that the trial of JTB should be off topic.  

The tech discussions are great for people that understand tech really well, but for those that don’t, they can come away with a feeling that POET can’t miss.  That’s an inevitable, but nevertheless unfortunate side effect. 

Share
New Message
Please login to post a reply